Organon & Co.
NYSE:OGN
| Market Cap (Intraday) | 2.56B |
| Current PE | 3.42 |
| Forward PE | 2.58 |
| 2yr Forward PE | 2.42 |
| 10-Day MA | $9.93 |
| 50-Day MA | $9.51 |
| 200-Day MA | $13.83 |
Organon & Co. Stock, NYSE:OGN
30 Hudson Street, 33rd floor, Jersey City, New Jersey 07302
United States of America
Phone: +1.551.430.6900
Number of Employees: 10000
Description
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women�s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.